Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$1.73 $0.03 (1.76%) RKDA stock closing price Oct 24, 2016 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Arcadia Biosciences, and helps in stock analysis. Financial strength can be guaged by performing Arcadia Biosciences stock analysis and by analyzing the balance sheet. Quarterly results announcements include the release of all three financial statements, of which the balance sheet is one. Arcadia Biosciences balance sheet as at the end of 2016-Q2 indicates an asset turnover ratio of 0.04M and debt to equity ratio of 0.8M. Whereas, Arcadia Biosciences revenue was $0.72M and Arcadia Biosciences operating cash flow was $-8.84M for the same period. View Arcadia Biosciences quarterly results to get the balance sheet details for the latest & last 40 quarters data..

show more
Get Balance sheet for another ticker
Fiscal year is Jan - Dec. 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1
Marketable Securities26.87M20.65M26.27M11.29M------
Raw Materials-----1.06M----
Work In Progress----------
Finished Goods-----1.56M----
Notes Receivable----------
Other Current Assets1.39M1.33M0.69M0.67M0.7M0.25M0.27M---
Arcadia Biosciences Total Current Assets
Property Plant & Equipment--5.24M---5.38M---
Accumulated Depreciation--4.65M---4.65M---
Arcadia Biosciences Net Property Plant & Equipment
Investment & Advances6.91M14.9M19.74M0.5M0.5M0.5M0.5M---
Other Non-Current Assets1.87M1.83M1.86M2.13M2.1M2.1M2.14M---
Deferred Charges----------
Deposits & Other Assets0.09M0.17M0.02M0.1M0.11M3.78M2.81M---
Arcadia Biosciences Total Assets
Notes Payable-5.6M4.56M-------
Accounts Payable2.57M2.79M2.42M3.97M4.67M3.38M3.19M---
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities1.5M1.36M1.02M3.28M3.65M4.31M2.46M---
Arcadia Biosciences Total Current Liabilities
Deferred Taxes/Income2.31M2.49M2.63M2.78M2.93M3.07M3.63M---
Convertible Debt----------
Long-Term Debt25.02M24.97M24.93M19.46M19.34M8.58M8.86M---
Non-Current Capital Leases----------
Other Long-Term Liabilities3M3M3M3M3M3M3M---
Arcadia Biosciences Total Liabilities
Minority Interest----------
Preferred Stock-----84.57M82.88M---
Common Stock Net0.04M0.04M0.04M0.04M0.04M-----
Capital Surplus172.91M172.58M172.22M171.85M171.33M27.89M29.2M---
Retained Earnings-141.66M-137.11M-131.92M-128.06M-123.45M-119.77M-113.97M---
Treasury Stock----------
Other Liabilities-0.01M-0.03M-0.11M-------
Arcadia Biosciences Shareholders Equity
Arcadia Biosciences Total Liabilities & Shareholders Equity
All figures in USD. M: Millions of USD, B: Billions of USD.

The latest Arcadia Biosciences stock price, and Arcadia Biosciences historical stock prices show the stock price movement over time, and the Arcadia Biosciences PE ratio chart displays the PE ratio movement. Apart from stock price, one should also look at balance sheet items which mainly comprise of the following:
  • Assets: An asset is a resource that a corporation like Arcadia Biosciences owns and has monetary significance. RKDA assets decreased from $70.1M in 2016-Q1 to $65.7M in 2016-Q2 . Assets can be of two types: fixed assets like real estate, plant and machinery; and current assets which includes cash, accounts receivable etc. Tech stocks typically don't have too many assets.
  • Liabilities: The total liabilities of Arcadia Biosciences for 2016-Q2 total to $34.42M. Liabilities for a company like Arcadia Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
Debt to Equity ratio
Asset Turnover
receivables turnover
PB ratio (
price to book ratio